Core Viewpoint - DWS has upgraded its rating for Nexperia from "Hold" to "Buy" following a significant increase in the company's net profit, which exceeded expectations, reaching approximately $63 million, representing a year-on-year growth of 305% and a half-year growth of 40% [1] Financial Performance - Nexperia's net profit for the first half of the year was approximately $63 million, which is a year-on-year increase of 305% and a half-year increase of 40% [1] - The gross margin increased by 1.5 percentage points year-on-year and by 0.6 percentage points half-yearly to 11.5%, driven by cost optimization measures, improved manufacturing efficiency, and restructuring efforts [1] Profit Forecast - DWS has revised its net profit forecasts for Nexperia for the years 2025 to 2027, increasing the estimates from $107 million, $125 million, and $146 million to $141 million, $164 million, and $193 million respectively [1] Target Price Adjustment - The target price for Nexperia has been raised from HKD 5 to HKD 10 following the positive financial results and outlook [1]
大行评级｜大华继显：耐世特上半年净利润超预期 上调目标价至10港元